“…4,10,11 Fortunately, the model of disease pathogenesis provided by Zeng and colleagues can direct clinical investigators toward a number of potential interventions that can reverse 1 or both of the aforementioned self-perpetuating cycles. 1 These experimental interventions include drugs that remove pro-inflammatory pathogens and microbial products (eg, valganciclovir for CMV, rifaximin for gut microbes, sevelamer for lipopolysaccharide), drugs that directly prevent fibrosis (eg, angiotensin II receptor antagonists and ACE inhibitors), and drugs that have more broad effects in reducing inflammation (eg, statins, nonsteroidal antinflammatory drugs, methotrexate, and mesalamine). Because disease is often easier to prevent than treat and the untreated phase of the infection is associated with persistent, highlevel inflammation and presumably progressive lymphoid fibrosis, then a reasonable conclusion from the body of work summarized here is for patients to start antiretroviral therapy as soon as possible.…”